Abstract
Purpose
Our goal was to use positron emission tomography (PET) to analyze the movement of radiolabeled agents in tissue to enable direct measurement of drug delivery to the brain.
Procedures
Various 11C- and 18 F-labeled compounds were delivered directly to an agarose phantom or rat striatum. Concentration profiles were extracted for analysis and fitted to diffusion models.
Results
Diffusion coefficients ranged from 0.075 ± 0.0026 mm2/min ([18 F]fluoride ion, 18 Da) to 0.0016 ± 0.0018 mm2/min ([18 F]NPB4-avidin, 68 kDa) and matched well with predictions based on molecular weight (R 2 = 0.965). The tortuosity of the brain extracellular space was estimated to be 1.56, with the tissue clearance halftime of each tracer in the brain varying from 19 to 41 min.
Conclusions
PET is an effective modality to directly quantify the movement of locally delivered drugs or drug carriers. This continuous, noninvasive assessment of delivery will aid the design of better drug delivery methods.
Similar content being viewed by others
References
Krewson CE, Klarman ML, Saltzman WM (1995) Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res 680:196–206
Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3–14
Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81
Neeves KB, Sawyer AJ, Foley CP, Saltzman WM, Olbricht WL (2007) Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles. Brain Res 1180:121–132
Tiwari SB, Amiji MM (2006) A review of nanocarrier-based CNS delivery systems. Curr Drug Deliv 3:219–232
Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH (1999) Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 90:315–320
Neeves KB, Lo CT, Foley CP, Saltzman WM, Olbricht WL (2006) Fabrication and characterization of microfluidic probes for convection enhanced drug delivery. J Control Release 111:252–262
Langer R (2001) Drug delivery. Drugs on target. Science 293:58–59
Gash DM, Zhang Z, Ai Y, Grondin R, Coffey R, Gerhardt GA (2005) Trophic factor distribution predicts functional recovery in parkinsonian monkeys. Ann Neurol 58:224–233
Peterson AL, Nutt JG (2008) Treatment of Parkinson’s disease with trophic factors. Neurotherapeutics 5:270–280
Salvatore MF, Ai Y, Fischer B et al (2006) Point source concentration of GDNF may explain failure of phase II clinical trial. Exp Neurol 202:497–505
Chen W, Cao Y, Liu M et al (2012) Rotavirus capsid surface protein VP4-coated Fe(3)O(4) nanoparticles as a theranostic platform for cellular imaging and drug delivery. Biomaterials 33:7895–7902
Chertok B, Moffat BA, David AE et al (2008) Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29:487–496
Janib SM, Moses AS, MacKay JA (2010) Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 62:1052–1063
Kim JH, Astary GW, Nobrega TL et al (2012) Dynamic contrast-enhanced MRI of Gd-albumin delivery to the rat hippocampus in vivo by convection-enhanced delivery. J Neurosci Methods 209:62–73
Zheng M, Sirianni R, Patel T et al (2010) [18F]PEG-biotin labeled nanoparticles for tracking drug delivery and tumor therapy. J Nucl Med 52:417
Polson A, van der RD (1950) Relationship between diffusion constants and molecular weight. Biochim Biophys Acta 5:358–360
Nicholson C, Phillips JM (1981) Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. J Physiol 321:225–257
Sykova E, Nicholson C (2008) Diffusion in brain extracellular space. Physiol Rev 88:1277–1340
Chen ZJ, Gillies GT, Broaddus WC et al (2004) A realistic brain tissue phantom for intraparenchymal infusion studies. J Neurosurg 101:314–322
Nicholson C, Tao L (1993) Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. Biophys J 65:2277–2290
Maaloum M, Pernodet N, Tinland B (1998) Agarose gel structure using atomic force microscopy: gel concentration and ionic strength effects. Electrophoresis 19:1606–1610
Laske DW, Morrison PF, Lieberman DM et al (1997) Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg 87:586–594
Acknowledgments
The authors gratefully acknowledge the contributions of the staff of the Yale PET Center, including Maria Corsi, Krista Fowles, Jim Ropchan, Patrick Ouellette, and Nancy Nishimura for their technical assistance. This work was supported by National Institutes of Health grant, T32DA022975, “Neuroimaging Sciences Training Program” and was also made possible by CTSA Grant Number UL1RR024139 from the National Center for Research Resources and the National Center for Advancing Translational Science, components of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.
Conflict of Interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sirianni, R.W., Zheng, MQ., Saltzman, W.M. et al. Direct, Quantitative, and Noninvasive Imaging of the Transport of Active Agents Through Intact Brain with Positron Emission Tomography. Mol Imaging Biol 15, 596–605 (2013). https://doi.org/10.1007/s11307-013-0636-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-013-0636-9